Advertisement
Advertisement
GELS
Gelteq Limited Ordinary Shares
0.70
USDSponsored
0.00
+0.57%
Apr 13, 10:49 UTC -4
Closed
After-Market
0.70
0.00
0.00%
GELS Earnings Reports
Positive Surprise Ratio
No Data Available for GELS
0%
Next Report
Date of Next Report
Jun 22, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Gelteq Limited Ordinary Shares earnings per share and revenue
On --, GELS reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Cyclerion Therapeutics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.38
Actual
-$0.21
Surprise
+45.82%
Cadrenal Therapeutics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.18
Actual
-$1.43
Surprise
-20.34%
Kairos Pharma, Ltd.
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.07
Surprise
-28.68%
Sunshine Biopharma Inc.
Report Date
Apr 03, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.54
Surprise
-96.08%
Palvella Therapeutics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.92
Actual
-$1.07
Surprise
-15.20%
Pharvaris N.V. Ordinary Shares
Report Date
Apr 02, 2026 For Q4 25
Estimate
-$0.63
Actual
-$0.72
Surprise
-13.69%
Nanobiotix S.A. - ADR
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.55
Actual
-$0.39
Surprise
-170.16%
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.44
Actual
-$1.91
Surprise
-32.66%
Innate Pharma S.A. ADS
Report Date
Apr 01, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.55
Surprise
-353.80%
FAQ
What were Gelteq Limited Ordinary Shares's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Gelteq Limited Ordinary Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Gelteq Limited Ordinary Shares's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Gelteq Limited Ordinary Shares expected to report next?
The next earning report is scheduled for Jun 22, 2026.
What are the forecasts for Gelteq Limited Ordinary Shares's next earnings report?
Based on --
analysts, Gelteq Limited Ordinary Shares is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement